Open an account

Claritev

CTEV · NYSE

$22.39+$0.43 (+1.96%)TodayMarket closed ·
Prev close $21.96

About CTEV

Claritev Corp. engages in providing data analytics and technology-enabled solutions. The company is headquartered in Mclean, Virginia and currently employs 3,000 full-time employees. The company went IPO on 2020-02-10. The Company’s services include analytics-based services, data & decision science services, network-based services, payment and revenue integrity, end-to-end surprise billing service, and Claritev payments. The firm uses its analytics-based services to price surprise bills and leverages reimbursement data from millions of claims repriced through these services and accepted by providers to assist in negotiations and calculate offers for arbitration when necessary. The company uses its payment integrity services on its network claims. The Company’s payment integrity offers advanced code editing, clinical negotiation, itemized bill review, coordination of benefits, subrogation, data mining, Medicare secondary payer validation, and end stage renal disease validation. The company provides solutions for the commercial market, government healthcare plans, and property and casualty healthcare payors.

Employees
3,000
Headquarters
McLean, Virginia
Listed
Feb 10, 2020
Sector
Health Care
Industry
Health Care Technology
Website
claritev.com

CTEV key statistics

Market cap
372.17M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
182.77K
Volume
199.39K
Open price
$22.30
High today
$22.79
Low today
$22.13
52 Week high
$73.68
52 Week low
$11.50

Claritev (CTEV) at a glance

As of Oct 20, 2026, Claritev (CTEV) shares are priced at $22.39, giving the company a market cap of 372.17M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $22.13 and $22.79. The current price is 1.2% above the day's low and 1.8% below its high.

Volume so far is 199.39K shares, in line with the average of 182.77K shares a day.

Over the past year Claritev has ranged from $11.50 to $73.68, and now sits 18% of the way up that range.

Claritev met or beat analyst EPS estimates in 3 of the last 8 quarters. In Q2 FY26 it reported -$3.49 per share against an estimate of -$4.21.

The average analyst price target is $46.92, 109.6% above the current price, from 5 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

80%of 5 analyst ratings say Buy
  • Buy80.0%
  • Hold20.0%
  • Sell0.0%
Price target · 7 analystsAvg $46.92
Low
$30.30
Now
$22.39
High
$76.65

CTEV earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 3 of the last 8 quarters, by 11.4% on average.

  1. Q3 FY24: reported -$24.25 per share against an estimate of -$13.97
  2. Q4 FY24: reported -$8.54 per share against an estimate of -$10.01
  3. Q1 FY25: reported -$3.90 per share against an estimate of -$3.16
  4. Q2 FY25: reported -$3.81 per share against an estimate of -$3.91
  5. Q3 FY25: reported -$4.23 per share against an estimate of -$3.67
  6. Q4 FY25: reported -$4.88 per share against an estimate of -$3.88
  7. Q1 FY26: reported -$4.41 per share against an estimate of -$4.09
  8. Q2 FY26: reported -$3.49 per share against an estimate of -$4.21

CTEV news

  • Press releaseBusiness Wire

    Claritev Selected by GDIT to Support CDC’s World Trade Center Health Program

  • Press releaseBusiness Wire

    Claritev Releases 2025 Corporate Responsibility Report

  • Press releaseBusiness Wire

    Claritev Appoints Ben Letham to its Board of Directors

  • Press releaseBusiness Wire

    Claritev Cares Helps Rural Patients Get Critical Care Closer to Home

  • Press releaseBusiness Wire

    Claritev Corporation Announces Participation in Upcoming Events

  • Press releaseBusiness Wire

    Marpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer Clients

  • Press releaseBusiness Wire

    Claritev Corporation Reports Second Quarter 2026 Results

  • Press releaseBusiness Wire

    Claritev Corporation Announces Participation in Canaccord Genuity 46th Annual Growth Conference

Similar companies

Companies in the same industry as Claritev

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.